Baxter Oncology GmbH
- L01 - Antineoplásicos
- ENDOXAN coated tablet 50 mg
- ENDOXAN powder for solution for injection 1 000 mg
- ENDOXAN powder for solution for injection 200 mg
- ENDOXAN powder for solution for injection 500 mg
- ONKOTRONE concentrate for solution for infusion 2 mg/ml
- V03 - Todos los demás preparados terapéuticos
- UROMITEXAN solution for infusion 100 mg/ml